查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600191

产后出血治疗设备市场：按产品、可用性、分销管道、应用 - 全球预测 2025-2030

Postpartum Hemorrhage Treatment Devices Market by Product, Usability, Distribution Channel, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年产后出血治疗器材市值为81,289万美元，预计2024年将达到8,6094万美元，复合年增长率为6.25%，预计到2030年将达到124295万美元。

产后出血 (PPH) 治疗设备是用于管理和控制产后出血过多的重要医疗工具，产后出血是全球孕产妇死亡的主要原因。这些医疗设备的需求源于需要透过提供快速有效的干预措施来确保孕产妇安全并降低死亡率。这些设备包括球囊填塞、非气动抗休克服、先进凝血剂等，主要应用于医院及产科诊所等医疗机构。这些设备的最终用途主要涉及产科医生、妇科医生和其他专注于优化孕产妇保健标准的孕产妇保健专业人员。

主要市场统计
基准年[2023] 81289万美元
预测年份 [2024] 86094万美元
预测年份 [2030] 12.4295亿美元
复合年增长率（%） 6.25%

该市场的主要成长要素是已开发地区和新兴地区对孕产妇健康的认识和重视程度的提高，以及医疗设备技术的进步。此外，医疗保健支出的增加以及政府改善孕产妇护理措施的支持也有助于市场扩张。潜在的商机包括开发具有成本效益的便携式设备，这在资源有限的环境中尤其重要。公司还可以利用数位技术进行设备使用培训和教育，从而提高医护人员的采用率。

限制市场成长的挑战包括先进设备的高成本、低收入地区的使用机会有限以及缺乏接受过使用这些设备培训的熟练医疗保健人员。监管障碍也对新参与企业和创新构成重大障碍。为了克服这些限制，创新可以集中于开发经济可行且用户友好的设备，这些设备整合了易于使用和监控的智慧技术。进一步的研究还可以探索解决产科护理多个方面的多功能设备的开发。市场仍在蓬勃发展，许多公司正在投资研发以提高设备的效率和安全性。相关人员应注重策略合作，以促进全球分销网络和培训计划，并确保 PPH 治疗设备的广泛采用和接受。

市场动态：快速发展的产后出血治疗设备市场的关键市场洞察

供需的动态交互作用正在改变产后出血治疗设备市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 妊娠併发症增加，如子宫倒置和多胎妊娠
    • 产后出血发生率高
    • 旨在延续医疗改革和改善孕产妇医疗服务的倡议
  • 市场限制因素
    • 产后出血治疗设备高成本
  • 市场机会
    • 技术进步与新型PPH治疗设备的推出
    • 针对产后出血等的真空引血控制装置的问世
  • 市场挑战
    • 缺乏训练有素的医疗保健提供者

波特五力：驾驭产后出血治疗设备市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解产后出血治疗设备市场的外部影响

外部宏观环境因素在塑造产后出血治疗设备市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解产后出血治疗器材市场竞争状况

产后出血治疗设备市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵产后出血治疗设备市场供应商的绩效评估

FPNV定位矩阵是评估产后出血治疗设备市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划产后出血治疗设备市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对产后出血治疗设备市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 妊娠併发症增加，例如子宫倒转和多胎妊娠
      • 产后出血发生率高
      • 持续推动医疗改革和改善妇幼保健服务的倡议
    • 抑制因素
      • 产后出血治疗设备费用高
    • 机会
      • 技术进步与新型PPH治疗设备的推出
      • 介绍用于产后出血等的吸引式止血装置。
    • 任务
      • 缺乏训练有素的医护人员
  • 市场区隔分析
    • 产品：使用非气动衝击服作为即时和临时措施的显着好处
    • 分销管道：优先考虑能快速获得产品的线下分销管道
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章产后出血治疗设备市场：副产品

  • 非气动衝击服
  • 预填充注射系统
  • 子宫填塞装置
    • 球囊填塞
    • Foley导管

第七章产后出血治疗设备市场：依可用性

  • 免洗装置
  • 可重复使用的装置

第八章产后出血治疗器材市场：依分销管道分类

  • 离线
  • 在线的

第九章产后出血治疗器材市场：依应用分类

  • 诊所
  • 医院

第十章北美及南美产后出血治疗器材市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太产后出血治疗器材市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东、非洲产后出血治疗器材市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Laborie Medical Technologies Corp. 收购 Urotronic, Inc. 以加强介入性泌尿系统产品组合
    • Medtrade 和 Kebomed Europe AG 联手加强整个欧洲的产后出血护理
  • 战略分析和建议

公司名单

  • 3RD Stone Design, Inc.
  • Bactiguard Holding AB
  • Becton, Dickinson and Company
  • Cardinal Health, Inc.
  • Cook Medical, Inc.
  • GE HealthCare Technologies, Inc.
  • Laborie Medical Technologies, Inc.
  • Merck & Co., Inc.
  • Organon & Co.
  • Procurenet Limited
  • Ribbel International Limited
  • Sinapi Biomedical
  • Teleflex, Inc.
  • Utah Medical Products Inc.
Product Code: MRR-DD5AD9F59CCA

The Postpartum Hemorrhage Treatment Devices Market was valued at USD 812.89 million in 2023, expected to reach USD 860.94 million in 2024, and is projected to grow at a CAGR of 6.25%, to USD 1,242.95 million by 2030.

Postpartum hemorrhage (PPH) treatment devices are essential medical tools designed to manage and control excessive bleeding following childbirth, a leading cause of maternal mortality globally. The necessity for these devices stems from the need to ensure maternal safety and reduce mortality rates by providing rapid and effective interventions. These devices, which include balloon tamponade, non-pneumatic anti-shock garments, and advanced blood clotting agents, are employed primarily in healthcare facilities such as hospitals and maternity clinics. The end-use of these devices predominantly involves obstetricians, gynecologists, and other maternity care professionals focused on optimizing maternal healthcare standards.

KEY MARKET STATISTICS
Base Year [2023] USD 812.89 million
Estimated Year [2024] USD 860.94 million
Forecast Year [2030] USD 1,242.95 million
CAGR (%) 6.25%

A key growth factor in this market is the increasing awareness and emphasis on maternal health in both developed and developing regions, alongside technological advancements in medical devices. Additionally, a rise in healthcare expenditures and support from government initiatives to improve maternal care contribute to market expansion. Potential opportunities include the development of cost-effective and portable devices, particularly crucial for resource-limited settings. Companies can also leverage digital technology for training and education on device usage, enhancing adoption rates among healthcare workers.

Challenges limiting market growth include the high cost of advanced devices, limited access in low-income regions, and a deficit of skilled healthcare professionals trained in the usage of such equipment. Regulatory hurdles also pose a significant barrier to entry for new players and innovations. To overcome these limitations, innovation could focus on creating economically viable, user-friendly devices that integrate smart technology for ease of use and monitoring. Further research could explore the development of multifunctional devices that address multiple aspects of obstetric care. The market remains dynamic, with numerous players investing in R&D to enhance device efficiency and safety. Stakeholders should focus on strategic collaborations to foster global distribution networks and training programs, ensuring the widespread implementation and acceptance of PPH treatment devices.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Postpartum Hemorrhage Treatment Devices Market

The Postpartum Hemorrhage Treatment Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in complications in pregnancy, such as inverted uterus and multiple pregnancies
    • High prevalence of postpartum hemorrhage
    • Ongoing healthcare reforms and initiatives aimed at improving maternal health services
  • Market Restraints
    • High cost of postpartum hemorrhage treatment devices
  • Market Opportunities
    • Technological advancements and launch of new PPH treatment devices
    • Emergence of vacuum-induced hemorrhage control device for postpartum hemorrhage and others
  • Market Challenges
    • Scarcity of trained healthcare providers

Porter's Five Forces: A Strategic Tool for Navigating the Postpartum Hemorrhage Treatment Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Postpartum Hemorrhage Treatment Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Postpartum Hemorrhage Treatment Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Postpartum Hemorrhage Treatment Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Postpartum Hemorrhage Treatment Devices Market

A detailed market share analysis in the Postpartum Hemorrhage Treatment Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Postpartum Hemorrhage Treatment Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Postpartum Hemorrhage Treatment Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Postpartum Hemorrhage Treatment Devices Market

A strategic analysis of the Postpartum Hemorrhage Treatment Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Postpartum Hemorrhage Treatment Devices Market, highlighting leading vendors and their innovative profiles. These include 3RD Stone Design, Inc., Bactiguard Holding AB, Becton, Dickinson and Company, Cardinal Health, Inc., Cook Medical, Inc., GE HealthCare Technologies, Inc., Laborie Medical Technologies, Inc., Merck & Co., Inc., Organon & Co., Procurenet Limited, Ribbel International Limited, Sinapi Biomedical, Teleflex, Inc., and Utah Medical Products Inc..

Market Segmentation & Coverage

This research report categorizes the Postpartum Hemorrhage Treatment Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Non-Pneumatic Anti-Shock Garment, Prefilled Injection System, and Uterine Tamponade Devices. The Uterine Tamponade Devices is further studied across Balloon Tamponade and Foley Catheter.
  • Based on Usability, market is studied across Disposable Devices and Reusable Devices.
  • Based on Distribution Channel, market is studied across Offline and Online.
  • Based on Application, market is studied across Clinics and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in complications in pregnancy, such as inverted uterus and multiple pregnancies
      • 5.1.1.2. High prevalence of postpartum hemorrhage
      • 5.1.1.3. Ongoing healthcare reforms and initiatives aimed at improving maternal health services
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of postpartum hemorrhage treatment devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements and launch of new PPH treatment devices
      • 5.1.3.2. Emergence of vacuum-induced hemorrhage control device for postpartum hemorrhage and others
    • 5.1.4. Challenges
      • 5.1.4.1. Scarcity of trained healthcare providers
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Significant benefits of non-pneumatic anti-shock garments as an immediate and temporary measure
    • 5.2.2. Distribution Channel: Higher preferences for offline distribution channels for quick product accessibility
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Postpartum Hemorrhage Treatment Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Non-Pneumatic Anti-Shock Garment
  • 6.3. Prefilled Injection System
  • 6.4. Uterine Tamponade Devices
    • 6.4.1. Balloon Tamponade
    • 6.4.2. Foley Catheter

7. Postpartum Hemorrhage Treatment Devices Market, by Usability

  • 7.1. Introduction
  • 7.2. Disposable Devices
  • 7.3. Reusable Devices

8. Postpartum Hemorrhage Treatment Devices Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Offline
  • 8.3. Online

9. Postpartum Hemorrhage Treatment Devices Market, by Application

  • 9.1. Introduction
  • 9.2. Clinics
  • 9.3. Hospitals

10. Americas Postpartum Hemorrhage Treatment Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Postpartum Hemorrhage Treatment Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Postpartum Hemorrhage Treatment Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Laborie Medical Technologies Corp. Acquires Urotronic, Inc. to Enhance Interventional Urology Portfolio
    • 13.3.2. Medtrade and Kebomed Europe AG Join Forces to Enhance Postpartum Hemorrhage Care Across Europe
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3RD Stone Design, Inc.
  • 2. Bactiguard Holding AB
  • 3. Becton, Dickinson and Company
  • 4. Cardinal Health, Inc.
  • 5. Cook Medical, Inc.
  • 6. GE HealthCare Technologies, Inc.
  • 7. Laborie Medical Technologies, Inc.
  • 8. Merck & Co., Inc.
  • 9. Organon & Co.
  • 10. Procurenet Limited
  • 11. Ribbel International Limited
  • 12. Sinapi Biomedical
  • 13. Teleflex, Inc.
  • 14. Utah Medical Products Inc.

LIST OF FIGURES

  • FIGURE 1. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY NON-PNEUMATIC ANTI-SHOCK GARMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PREFILLED INJECTION SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY BALLOON TAMPONADE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY FOLEY CATHETER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISPOSABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY REUSABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. SOUTH KOREA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. TAIWAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. THAILAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. VIETNAM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 127. DENMARK POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. EGYPT POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. FINLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. FRANCE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. GERMANY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. ISRAEL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. ITALY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. NETHERLANDS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. NIGERIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NORWAY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. POLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. QATAR POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. RUSSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. SAUDI ARABIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SPAIN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SWEDEN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SWITZERLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. TURKEY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. UNITED ARAB EMIRATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED KINGDOM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 233. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023